Impact of early tumor shrinkage and depth of response in patients with BRAF V600E-mutant metastatic colorectal cancer.

被引：0
|
作者：
Udagawa, Shohei [1 ]
Osumi, Hiroki [1 ]
Ooki, Akira [1 ]
Wakatsuki, Takeru [1 ]
Fukuoka, Shota [1 ]
Yoshino, Koichiro [1 ]
Tamba, Mikako [1 ]
Ogura, Mariko [1 ]
Takahari, Daisuke [1 ]
Chin, Keisho [1 ]
Yamaguchi, Kensei [1 ]
Shinozaki, Eiji [1 ]
机构：
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
283-237-255; 261-492-3532-2370-7650-2700; 261-566-148; 261-492-9019; 298-145-222-184-4809-5347; 3282-415; 7; 6; 4; 3; 2; 38092-18849; 38092-22188; 1;
D O I：
10.1200/JCO.2024.42.3_suppl.142
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：142 / 142
页数：1
相关论文
共 50 条
  • [21] Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC
    Planchard, David
    Besse, Benjamin
    Groen, Harry J. M.
    Hashemi, Sayed M. S.
    Mazieres, Julien
    Kim, Tae Min
    Quoix, Elisabeth
    Souquet, Pierre-Jean
    Barlesi, Fabrice
    Baik, Christina
    Villaruz, Liza C.
    Kelly, Ronan J.
    Zhang, Shirong
    Tan, Monique
    Gasal, Eduard
    Santarpia, Libero
    Johnson, Bruce E.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (01) : 103 - 115
  • [22] BRAFV600E-Mutant V600E-Mutant Metastatic Colorectal Cancer: Current Evidence, Future Directions, and Research Priorities
    Piercey, Oliver
    Tie, Jeanne
    Hollande, Frederic
    Wong, Hui-Li
    Mariadason, John
    Desai, Jayesh
    CLINICAL COLORECTAL CANCER, 2024, 23 (03) : 215 - 229
  • [23] New hope for patients with BRAF V600E-mutant anaplastic thyroid cancer: lights and shadows
    Grani, Giorgio
    Filetti, Sebastiano
    Durante, Cosimo
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (08) : 2796 - 2801
  • [24] Molecular correlates of clinical benefit in previously treated patients (pts) with BRAF V600E-mutant metastatic colorectal cancer (mCRC) from the BEACON study
    Desai, Jayesh
    Kopetz, Scott
    Murphy, Danielle A.
    Pu, Jie
    Ciardiello, Fortunato
    Grothey, Axel
    Van Cutsem, Eric
    Wasan, Harpreet Singh
    Yaeger, Rona
    Yoshino, Takayuki
    Chantrill, Lorraine
    Tebbutt, Niall
    Strickland, Andrew
    Price, Timothy
    Karapetis, Chris
    Murphy, Felicity
    Donahue, Amber C.
    Golden, Adele
    Gollerkeri, Ashwin
    Zhu, Zhou
    Tabernero, Josep
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 89 - 89
  • [25] Overcoming resistance in a BRAF V600E-mutant adenocarcinoma of the lung
    Schmid, T.
    Buess, M.
    CURRENT ONCOLOGY, 2018, 25 (03) : E217 - E219
  • [26] A secondary mutation in BRAF confers resistance to RAF inhibition in a BRAF V600E-mutant brain tumor
    Wang, Jiawan
    Yao, Zhan
    Jonsson, Philip
    Allen, Amy
    Qin, Alice Can Ran
    Uddin, Sharmeen
    Dunkel, Ira J.
    Petriccione, Mary
    Manova, Katia
    Haque, Sofia
    Rosenblum, Marc
    Pisapia, David J.
    Rosen, Neal
    Taylor, Barry S.
    Pratilas, Christine A.
    CANCER RESEARCH, 2018, 78 (13)
  • [27] Antitumor activity of panRAF inhibition in BRAF V600E metastatic colorectal cancer.
    Sorokin, Alex
    Bitner, Lea
    Wu, Ji
    Menter, David
    Kopetz, Scott
    Morris, Van Karlyle
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [28] Prognostic impact of depth of response and early tumour shrinkage in patients with BRAFV600E-mutated metastatic colorectal cancer treated with targeted therapy
    Vetere, Guglielmo
    Germani, Marco Maria
    Antoniotti, Carlotta
    Salvatore, Lisa
    Pietrantonio, Filippo
    Lonardi, Sara
    Bensi, Maria
    Ghelardi, Filippo
    Calegari, Maria Alessandra
    Intini, Rossana
    Minelli, Alessandro
    Sullo, Francesco Giulio
    Boccaccio, Chiara
    Taravella, Ada
    Puccini, Alberto
    Lavacchi, Daniele
    Noto, Laura
    Salati, Massimiliano
    Scartozzi, Mario
    Cremolini, Chiara
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2025, 17
  • [29] Impact of synchronous vs metachronous primary tumor resection on prognosis of BRAF-V600E mutant metastatic colorectal cancer (mCRC).
    Ahmed, Arwa Isameldin
    Philips, William
    Marginean, Horia
    Asmis, Timothy R.
    Vickers, Michael M.
    Lo, Bryan
    Goodwin, Rachel Anne
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL)
  • [30] Molecular correlates of clinical benefit in previously treated patients (pts) with BRAF V600E-mutant metastatic colorectal cancer (mCRC) from the BEACON study.
    Kopetz, Scott
    Murphy, Danielle A.
    Pu, Jie
    Ciardiello, Fortunato
    Desai, Jayesh
    Grothey, Axel
    Van Cutsem, Eric
    Wasan, Harpreet Singh
    Yaeger, Rona
    Yoshino, Takayuki
    Donahue, Amber C.
    Golden, Adele
    Gollerkeri, Ashwin
    Zhu, Zhou
    Tabernero, Josep
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345